The Virginia House of Delegates has approved House Bill 1989, a measure that updates labeling requirements for medical marijuana products and expands delivery options for registered patients.
Filed on January 7 by Delegate Alex Askew (D), the bill advanced through the General Laws Committee with a 19-3 vote on January 28, and today was approved by the House of Delegates through its second reading. Once approved through a third and final reading, it will be sent to the state’s Senate for consideration.
If enacted, the bill would require pharmaceutical processors to provide more detailed labeling on medical marijuana products, including:
- The total milligrams of tetrahydrocannabinol (THC) and cannabidiol (CBD) in edible and topical cannabis products.
- The milligrams of THC and CBD per serving for these product types.
- The total percentage of THC and CBD in inhalable cannabis products.
Under current law, labels must include the total percentage and milligrams of THC and CBD in a product, as well as the milligrams per serving. The bill’s updates is an attempt to provide greater clarity for patients regarding cannabinoid content.
HB 1989 also allows pharmaceutical processors and cannabis dispensing facilities to deliver medical marijuana products directly to patients, their registered agents, parents, or legal guardians at any lawful residence or business. However, deliveries would be prohibited at public gathering places.
